VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.4881
+0.0140 (2.95%)
Aug 19, 2026, 4:00 PM EDT - Market closed
VolitionRx Revenue
VolitionRx had revenue of $398.66K in the quarter ending June 30, 2026, a decrease of -1.97%. This brings the company's revenue in the last twelve months to $2.46M, up 86.32% year-over-year. In the year 2025, VolitionRx had annual revenue of $1.73M with 40.04% growth.
Revenue (ttm)
$2.46M
Revenue Growth
+86.32%
P/S Ratio
1.65
Revenue / Employee
$36,687
Employees
67
Market Cap
4.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.73M | 493.87K | 40.04% |
| Dec 31, 2024 | 1.23M | 458.21K | 59.10% |
| Dec 31, 2023 | 775.30K | 468.91K | 153.04% |
| Dec 31, 2022 | 306.39K | 216.36K | 240.30% |
| Dec 31, 2021 | 90.04K | 76.60K | 570.25% |
| Dec 31, 2020 | 13.43K | -3.66K | -21.43% |
| Dec 31, 2019 | 17.10K | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | 54.97K | - | - |
| Dec 31, 2011 | - | - | - |
| Aug 31, 2011 | - | - | - |
| Aug 31, 2010 | - | - | - |
| Aug 31, 2009 | - | - | - |
| Aug 31, 2008 | - | - | - |
| Aug 31, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 20.90M |
| WORK Medical Technology Group LTD | 10.72M |
| Nuwellis | 9.01M |
| Beyond Air | 7.69M |
| Picard Medical | 5.47M |
| Tenon Medical | 5.31M |
| Biomerica | 4.33M |
| Intelligent Bio Solutions | 4.22M |
VNRX News
- 2 days ago - VolitionRx reports results from lateral flow finger prick sample test for sepsis - TheFly
- 3 days ago - VolitionRx reports Q2 revenue $400K, consensus $474.34K - TheFly
- 5 days ago - VolitionRx Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - VolitionRx Earnings release: Q2 2026 - Filings
- 5 days ago - VolitionRx Quarterly report: Q2 2026 - Filings
- 6 days ago - VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update - PRNewsWire
- 7 days ago - Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients - PRNewsWire
- 8 days ago - VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update - PRNewsWire